Severe anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis with prolonged hyperammonemia: a case report
Abstract Background Anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis (Anti-AMPAR-E) is a very rare subtype of autoimmune encephalitis, typically presenting with memory decline, seizures, and changes in psychosis and behavior. Anti-AMPAR-E is often associated with the p...
Saved in:
Main Authors: | Chunxia Yan, Lingling Bai, Jingwei Du, Zonglei Chong, Guangjun Xu, Xiaoqian Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Neurology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12883-025-04040-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunomediated Encephalitis: New Diagnoses on the Neurology–Psychiatry Interface
by: Daniel Damiani, et al. -
Glutamine-glutamate centered metabolism as the potential therapeutic target against Japanese encephalitis virus-induced encephalitis
by: Mengyuan Li, et al.
Published: (2025-01-01) -
Autoimmune encephalitis: case reports of anti-NMDAR and anti-CASPR2 encephalitides and literature review
by: J. Kazlauskaitė, et al.
Published: (2021-12-01) -
Investigation of the association between circulating inflammatory proteins and encephalitis risk in Europeans by two-sample Mendelian randomization analysis
by: Yanwei Liu, et al.
Published: (2025-02-01) -
Efficacy of rituximab as second-line therapy for autoimmune encephalitis: A systematic review and meta-analysis
by: Lin-ming Zhang, et al.
Published: (2025-01-01)